biochemical basis enhanced drug bioavailability piperine evidence piperine potent inhibitor drug metabolism pubmed ncbi abstract piperine major active component black long peppers reported enhance drug bioavailability present studies aimed understanding interaction piperine enzymatic drug biotransforming reactions hepatic tissue vitro vivo piperine inhibited arylhydrocarbon hydroxylation ethylmorphine-n-demethylation num ethoxycoumarin-o-deethylation num hydroxy-benzo a pyrene glucuronidation rat postmitochondrial supernatant vitro dose-dependent manner piperine inhibition reactions postmitochondrial supernatant num methylcholanthrene phenobarbital-treated rats similar controls inhibition piperine arylhydrocarbon hydroxylase ahh num methylcholanthrene-treated rats comparable observed num benzoflavone piperine caused noncompetitive inhibition hepatic microsomal ahh untreated num methylcholanthrene-treated rats ki num microm close apparent km ahh observed controls similarly kinetics inhibition ethylmorphine-n-demethylase control rat liver microsomes exhibited noncompetitive inhibition apparent km num mm ki num microm studies demonstrated piperine nonspecific inhibitor drug metabolism shows discrimination cytochrome num forms oral administration piperine rats strongly inhibited hepatic ahh udp-glucuronyltransferase activities maximal inhibition ahh observed num hr restored normal num hr pretreatment piperine prolonged hexobarbital sleeping time zoxazolamine paralysis time mice half dose skf num results demonstrate piperine potent inhibitor drug metabolism 
